Auro Laboratories Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018

Auditor and Management Disclosures and Notes for the quarterly results dated 31 Dec 2018

1. The above unaudited financial results for the quarter ended 31st December, 2018 were reviewed by the Audit Committee and thereafter approved by the Board of Directors at meeting held on 29th January, 2019.

2. The Company operates in single segment i.e. "Pharmaceuticals", and hence does not have any additional disclosure to be made under Ind As 108 on operating Segments.

3. Limited review has been carried out by the Statutory Auditors of the Company.

Siddhartha Deorah
Whole Time Director